PSA Screening Benefits Still Unclear After Two Studies Reveal Interim Data
This article was originally published in The Gray Sheet
Executive Summary
Experts are still debating the value of prostate cancer screening after reviewing interim data from two ongoing studies published in the March 26 New England Journal of Medicine